1
|
Eosinophils are required for the maintenance of plasma cells in the bone marrow.
|
Nat Immunol
|
2011
|
2.83
|
2
|
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
|
J Exp Med
|
2012
|
2.36
|
3
|
TLR-activated B cells suppress T cell-mediated autoimmunity.
|
J Immunol
|
2008
|
2.25
|
4
|
Memory B and memory plasma cells.
|
Immunol Rev
|
2010
|
1.95
|
5
|
Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection.
|
Immunity
|
2010
|
1.75
|
6
|
Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.
|
Eur J Immunol
|
2006
|
1.57
|
7
|
Beta1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response.
|
Immunity
|
2002
|
1.38
|
8
|
Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity.
|
Immunol Rev
|
2010
|
1.22
|
9
|
Plasma cell differentiation in T-independent type 2 immune responses is independent of CD11c(high) dendritic cells.
|
Eur J Immunol
|
2006
|
1.05
|
10
|
Teleost fish mount complex clonal IgM and IgT responses in spleen upon systemic viral infection.
|
PLoS Pathog
|
2013
|
1.03
|
11
|
Activation of CD4⁺ Foxp3⁺ regulatory T cells proceeds normally in the absence of B cells during EAE.
|
Eur J Immunol
|
2012
|
1.02
|
12
|
Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
|
J Immunol
|
2011
|
1.01
|
13
|
A new role of CTLA-4 on B cells in thymus-dependent immune responses in vivo.
|
J Immunol
|
2007
|
0.98
|
14
|
Activated B cells in autoimmune diseases: the case for a regulatory role.
|
Nat Clin Pract Rheumatol
|
2008
|
0.97
|
15
|
The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells.
|
Eur J Immunol
|
2007
|
0.93
|
16
|
Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease.
|
Eur J Immunol
|
2014
|
0.91
|
17
|
Immune regulation by B cells and antibodies a view towards the clinic.
|
Adv Immunol
|
2008
|
0.89
|
18
|
Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation.
|
J Transl Med
|
2013
|
0.88
|
19
|
CD83 is a regulator of murine B cell function in vivo.
|
Eur J Immunol
|
2007
|
0.87
|
20
|
T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
|
J Immunol
|
2007
|
0.85
|
21
|
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis.
|
Eur J Immunol
|
2011
|
0.85
|
22
|
IRF4 - a factor for class switching and antibody secretion.
|
Nat Immunol
|
2006
|
0.84
|
23
|
Interleukin-10-producing B cells and the regulation of immunity.
|
Curr Top Microbiol Immunol
|
2014
|
0.81
|
24
|
NKT cells determine titer and subtype profile of virus-specific IgG antibodies during herpes simplex virus Infection.
|
J Immunol
|
2014
|
0.81
|
25
|
Intrinsic Toll-like receptor signalling drives regulatory function in B cells.
|
Front Biosci (Elite Ed)
|
2013
|
0.80
|
26
|
Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10).
|
Gene
|
2002
|
0.79
|
27
|
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
|
Arthritis Res Ther
|
2014
|
0.78
|
28
|
Functional interactions between B lymphocytes and the innate immune system.
|
Infect Disord Drug Targets
|
2012
|
0.77
|
29
|
B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"?
|
Eur J Immunol
|
2014
|
0.77
|
30
|
Utilization of a lentiviral system for the generation of B cells with regulatory properties.
|
Methods Mol Biol
|
2014
|
0.76
|
31
|
Editorial: B lymphocytes as programmers and effectors of immunity, their roles beyond antibody production.
|
Infect Disord Drug Targets
|
2012
|
0.75
|
32
|
A method for the generation of TCR retrogenic mice.
|
Methods Mol Biol
|
2014
|
0.75
|